Is a Skin Procedure in Korea Safe? What Approval Doesn't Tell You

A product's approval and a procedure's safety are two separate questions. A treatment can carry every regulatory stamp a patient could ask for and still be delivered inside a consultation structure that puts a short-stay visitor at risk. We see this gap constantly in how patients evaluate a clinic before they book, and it is the reason we start every visit with a diagnosis rather than a treatment name.

Why more visitors are asking this question now

More foreign patients are asking us to explain the difference between product approval and procedure safety, and the timing makes sense. According to the Ministry of Health and Welfare, 2.01 million foreign patients visited Korea in 2025, the first time the figure has passed two million since the ministry began compiling this data in 2009, and dermatology accounted for the largest share of visits by department. Seoul drew about 87.2% of those patients, concentrated in districts with a dense cluster of dermatology and aesthetic clinics.

That growth means more visitors are booking treatments they cannot easily access at home, on trips measured in days rather than weeks. A short stay changes what "safe" needs to mean. It is no longer just about whether a product cleared a regulatory review. It is about whether the diagnosis, the person performing the treatment, and the recovery plan can all hold up inside a five-day itinerary.

What product approval actually covers, and what it leaves out

Regulatory approval, whether from Korea's Ministry of Food and Drug Safety or a CE mark in Europe, verifies a product's ingredients and manufacturing standards. It says nothing about three things that determine whether a specific visit goes well.

The first is menu-first consultation, where a patient is asked to choose a treatment name before anyone has assessed their skin. When the treatment is selected before the diagnosis, the product may be approved and the outcome still mismatched to the patient's actual skin condition.

The second is the gap between the doctor who consults and the doctor who treats. This is not a theoretical risk. Under the Medical Service Act, ordering or performing an unlicensed medical act carries a maximum penalty of five years in prison or a fine of up to 50 million won, according to CNN's reporting on enforcement cases. Legal commentary on these cases has also noted that penalties are applied inconsistently and are often lighter than the maximum, which is part of why the practice persists despite being illegal. For a patient who flew in for a specific consultation, discovering after the fact that someone else performed the procedure is a different problem than a mislabeled product.

The third is what happens after the needle or device leaves the room. On a short visit, if recovery management is skipped, swelling or bruising can run past the days a patient has left before their flight home, turning a planned outcome into an unplanned one.

What we check before we treat

We do not start with a treatment name. We start with a diagnosis, and the product and dosage are designed around what that diagnosis finds, not the other way around. The doctor who runs the consultation is the same doctor who performs the procedure, so there is no handoff between the person who made the assessment and the person holding the device. Our Gangnam location keeps Japanese, Chinese, and English interpreters on site, so the consultation itself does not depend on a patient's Korean.

Both of our locations operate inside UHC group hotel buildings rather than as separate clinics with a referral arrangement to a hotel down the street. That means a guest staying at the hotel can use the oxygen chamber and vitamin IV drip as an on-site amenity after treatment, without adding a separate trip across the city during the days that matter most for recovery.

Five things to confirm before you book

• Whether the consultation starts with a skin diagnosis or with a menu of treatment names to choose from.
• Whether the doctor who consults with you is the same doctor who will perform the procedure.
• Whether there is a recovery space and dedicated staff available after treatment, not just a room to sit in.
• Whether the product has domestic approval and whether the person performing the treatment holds the license required for it.
• Whether the total quoted cost includes any broker fee. Note that as of December 31, 2025, Korea's Ministry of Economy and Finance ended the VAT refund program that had applied to foreign patients' cosmetic and dermatological procedures, so price references in older reviews or posts should be treated as outdated rather than current.

FAQ

If a product has Ministry of Food and Drug Safety approval, is the procedure automatically safe?

No. Approval applies to the product itself, ingredients and manufacturing standards. Procedure safety depends on the diagnosis, who performs the treatment, and how recovery is managed, none of which a product approval certifies.

How can I confirm the doctor I consult with is the doctor who treats me?

Ask directly before booking whether the consulting doctor performs the procedure personally, and ask whether you would be asked to sign a new consent form if the assigned medical staff changed for any reason.

Can I get recovery support on the same day as my procedure?

At our Gangnam and Seocho locations, both inside UHC group hotel buildings, guests staying at the hotel can use the oxygen chamber and vitamin IV drip as an on-site amenity after their procedure, without traveling elsewhere in the city.

Does the VAT refund for cosmetic treatments still apply in 2026?

No. The refund program for foreign patients' cosmetic and dermatological procedures ended on December 31, 2025, so patients budgeting for a 2026 visit should plan around the full quoted price rather than a refunded amount.